Quintrio
Home

Stock overview

Prenetics Global Limited Class A Ordinary Share

PRE

Prenetics Global Ltd is a consumer health and wellness company offering nutrition and longevity products through its flagship brand, IM8. It offers science-backed daily nutrition and longevity products distributed directly to consumers across multiple countries. The company's products are developed with scientific input and are subject to third-party quality certifications.

Last trade $16.03
Day change +$0.545 (+3.52%)
Day range $15.23 – $16.24
Volume 142,388
Market cap $302M

Open XNAS

Fundamentals

Key company ratios and reported financial statements.

Source: Massive.com

Key ratios

No ratio data was found for PRE.

Financial statements

Income and cash flow amounts are for the period; balance sheets are point-in-time snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are displayed when available.

No quarterly income statement data was found for PRE.

Recent news

Company coverage with links to the original publishers.

Publication times in UTC
GlobeNewswire Inc.

Prenetics’ IM8 CEO and CFO Purchase $1.0 Million of Shares in the Open Market Following Second Quarter Results

Prenetics Global Limited (NASDAQ: PRE) announced that CEO Danny Yeung and CFO Brian Rosin purchased $1.0 million in company shares during August 2026, bringing cumulative leadership investment to $3.75 million since November 2025. The purchases follow strong Q2 2026 results with total revenue up 288% YoY to $46.5 million, IM8 revenue reaching $45.0 million (up 359% YoY), and the company achieving its first month of positive consolidated Adjusted Free Cash Flow in July. Prenetics raised FY 2026 revenue guidance to $220-230 million and introduced FY 2027 guidance of over $400 million.

GlobeNewswire Inc.

Prenetics’ IM8 Secures $1 Billion Growth Financing from General Catalyst’s Customer Value Fund (CVF)

Prenetics Global Limited announced a $1 billion growth financing deal with General Catalyst's Customer Value Fund to accelerate IM8's marketing spend. The company raised its full-year 2026 revenue guidance to $210-220 million (from $190-210 million) and projects $300 million annualized run-rate by year-end 2026 and $400+ million in full-year 2027 revenue. IM8, co-founded by David Beckham, has become the fastest-growing premium supplement brand ever, delivering 200,000 servings daily across 43 countries with strong unit economics ($1.44 gross profit return per $1 acquisition spend).

GlobeNewswire Inc.

Prenetics' IM8 Partners with Superpower to Personalize the Future of Supplementation

Prenetics Global Limited's IM8 brand has partnered with Superpower to create an integrated health platform combining clinical-grade supplements with comprehensive blood biomarker testing. IM8 90-day subscribers can access Superpower's annual blood testing membership for $49 (75% discount), while Superpower members gain access to IM8's Daily Ultimate Essentials at preferred rates. The partnership aims to provide measurable proof of supplement efficacy through a closed-loop testing and supplementation system.

GlobeNewswire Inc.

Personalized Nutrition Market Set to Reach $30.94 Billion by 2030 at 14.4% CAGR | Asia Pacific Emerging as a High-Growth Hub

The global personalized nutrition market is projected to grow from $15.79 billion in 2025 to $30.94 billion by 2030 at a 14.4% CAGR. Digital tools and active measurement technologies are the fastest-growing segments, while Asia Pacific emerges as a high-growth regional hub driven by expanding middle class, rising lifestyle diseases, and rapid digital health adoption.

GlobeNewswire Inc.

Prenetics Completes $70 Million Insighta Sale to Tencent, Bolstering Balance Sheet to $171.1 Million in Total Adjusted Liquidity

Prenetics Global Limited completed the sale of its 35% equity interest in Insighta to Tencent for $70 million in cash, bringing total adjusted liquidity to $171.1 million. The company operates with zero debt and plans to use the proceeds to accelerate IM8's global expansion. IM8, co-founded with David Beckham, has achieved over $100 million in annualized recurring revenue within 11 months and is sold in more than 30 countries.

Dividends

Declared distributions and recorded event dates. Forecasts are not shown.

Updated daily

No declared upcoming dividend found.

Ex-dividendAmount / sharePay dateType
Feb 17, 2016$10.50Mar 1, 2016unknown
Nov 4, 2015$10.50Dec 1, 2015recurring
Aug 5, 2015$10.50Sep 1, 2015recurring
May 6, 2015$10.50Jun 1, 2015recurring
Feb 11, 2015$10.50Feb 27, 2015recurring

Stock splits

Historical share-structure events and their execution dates.

Updated daily
Execution dateSplit ratioEvent type
Nov 14, 20231-for-15reverse split